The effect of combined oral contraceptives containing drospirenone and ethinylestradiol on serum levels of amino acids and acylcarnitines

被引:0
|
作者
Albe Swanepoel
Janette Bester
Yolanda Kruger
Elmarie Davoren
Ilse du Preez
机构
[1] North-West University,Faculty of Health Sciences, Centre of Excellence for Nutrition
[2] University of Pretoria,Department of Physiology, Faculty of Health Sciences, School of Medicine
[3] North-West University,Human Metabolomics, Faculty of Natural and Agricultural Sciences
来源
Metabolomics | 2021年 / 17卷
关键词
Combined oral contraceptives; Amino acids; Acylcarnitines; Drospirenone; Ethinylestradiol; Antioxidant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] The effect of combined oral contraceptives containing drospirenone and ethinylestradiol on serum levels of amino acids and acylcarnitines
    Swanepoel, Albe
    Bester, Janette
    Kruger, Yolanda
    Davoren, Elmarie
    du Preez, Ilse
    METABOLOMICS, 2021, 17 (09)
  • [2] Serum Metabolome Changes in Relation to Prothrombotic State Induced by Combined Oral Contraceptives with Drospirenone and Ethinylestradiol
    Swanepoel, Albe Carina
    Bester, Janette
    Emmerson, Odette
    Soma, Prashilla
    Beukes, Derylize
    van Reenen, Mari
    Loots, Du Toit
    du Preez, Ilse
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2020, 24 (07) : 404 - 414
  • [3] Is it ethical to use drospirenone-containing combined oral contraceptives?
    Pittrof, Rudiger
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2012, 38 (03): : 205 - 206
  • [4] Is it ethical to use drospirenone-containing combined oral contraceptives?: Response
    Dinger, Juergen
    Shapiro, Samuel
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2012, 38 (03): : 206 - 207
  • [5] Prothrombotic changes in users of new combined oral contraceptives containing drospirenone
    Van Vliet, HAAM
    Winkel, TA
    Noort, I
    Rosendaal, FR
    Rosing, J
    Helmerhorst, FM
    THROMBOSIS RESEARCH, 2005, 115 : 145 - 146
  • [6] A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism
    Gaspard, U
    Scheen, A
    Endrikat, J
    Buicu, C
    Lefebvre, P
    Gerlinger, C
    Heithecker, R
    CONTRACEPTION, 2003, 67 (06) : 423 - 429
  • [7] Health outcomes in women taking ethinylestradiol/drospirenone and other oral contraceptives
    Loughlin, Jeanne
    Seeger, John
    Eng, P. Mona
    Clifford, C. Robin
    Cutone, Jennifer
    Walker, Alexander
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S72 - S73
  • [8] Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives
    Loughlin, Jeanne
    Seeger, John D.
    Eng, P. Mona
    Foegh, Marie
    Clifford, C. Robin
    Cutone, Jennifer
    Walker, Alexander M.
    CONTRACEPTION, 2008, 78 (05) : 377 - 383
  • [9] Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism
    Jonderko, Krzysztof
    Skalba, Piotr
    Kasicka-Jonderko, Anna
    Kaminska, Magdalena
    Bizior-Frymus, Dorota
    Dyja, Renata
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2013, 18 (04): : 284 - 292
  • [10] Risk of thromboembolism in women taking Ethinylestradiol/Drospirenone and other oral contraceptives
    Seeger, John D.
    Loughlin, Jeanne
    Eng, P. Mona
    Clifford, C. Robin
    Cutone, Jennifer
    Walker, Alexander M.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (03): : 587 - 593